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Cardiovascular Morbidity and Mortality
in Type 2 Diabetic Patients: a 22-year 
Historical Cohort Study in Dutch 
General Practice
W.J.C. de Grauw, E.H. van de Lisdonk, H.J.M. van den Hoogen, C. van Weel
Department o f  General Practice and Social Medicine, University o f  
Nijmegen, The Netherlands
A historical cohort study was performed to assess cardiovascular morbidity and mortality 
in Type 2 (non-insulin-dependent) diabetic patients. The data were collected from 1967 
to 1989 in four Dutch general practices performing the Continuous Morbidity Registration 
Nijmegen. Each newly diagnosed Type 2 diabetic patient fulfilling the WHO criteria 
(n =  265) was matched to a control patient for practice, sex, age, and social class. 
Inclusion started in 1967, the first year of the still ongoing, Continuous Morbidity 
Registration Nijmegen. On average, a follow-up of 6.8 years (range 1 month-22 years) 
was realized. Compared to the non-diabetic control patients, the Type 2 diabetic patients 
showed higher cardiovascular morbidity (risk ratio 1.76, 95 % Cl 1.34-2.30) and a higher 
mortality rate (risk ratio 1,54, 95 % Cl 1.07-2.23), Mortality after 10 years was 36 % vs 
20 % (p <  0.01), the median survival time 16 years vs 19 years. The cumulative survival 
rates were significantly different (p < 0 .0 1 )  between patients and controls in the age 
group 65-74 years. The higher mortality in Type 2 diabetic patients was completely due 
to an excess of cardiovascular death (risk ratio 2.05, 95 % Cl 1.24—3.37).
key w o rd s  Type 2 diabetes Cardiovascular morbidity Mortality General practice
Introduction Patients and Methods
In the Netherlands, as in the United Kingdom, the 
majority of Type 2 (non-insulin-dependent) diabetic 
patients are treated in general practice.1 * However/ 
knowledge about Type 2 diabetes is mainly based on 
patient groups selected from hospital care.4 It is apparent 
that Type 2 diabetes can be characterized as a risk factor 
for cardiovascular disease/"’ particularly for stroke,0 
ischaemic heart disease,7*“  and peripheral vascular 
disease/1 The prevalence of hypertension is also higher, 1(1 
Panzram has reported an increased mortality in Type 
2 diabetes, particularly in females.n He has stated that 
mortality statistics on diabetes are frequently biased by 
factors including referral bias in hospital populations. 
The most reliable results can be expected from prospective 
studies of defined cohorts recruited from general practice 
population surveys. 12 This paper reports an analysis of 
cardiovascular morbidity and causes of death in a cohort 
of Type 2 diabetic patients from general practice covering 
an observation period of up to 22 years. The aim of the 
study was to assess the impact of cardiovascular morbidity 
and mortality on Type 2 diabetic patients in general 
practice.
Correspondence to: Dr W.J.C. de Grauw, Department of General 
Practice and Soc ial Medicine, Postbus 9101, 6500 MB Nijmegen, The 
Netherlands.
Continuous M orb id ity  Registration 
Nijmegen
The ongoing Continuous M orb id ity  Registration Nijmegen 
started in 1967 in four general practices in and around 
N ijm egen/ ;1 This registration aims to study the epidem iol­
ogical aspects o f diseases in general practice, including 
the incidence, prevalence, and the course of the disease 
in time.
Every episode of illness seen by or reported to the 
general practitioner (GP) is registered as soon as it is 
established. In the Netherlands specialist care is only 
available after referral by the GP, and for the specialist 
it is a routine procedure to report back to the GP about 
diagnosis and treatment in referred patients. A ll referrals 
and specialist-reported diagnoses are also recorded in 
the registration system. To register diagnoses the adapted 
E-list14 is used, with a fourth d ig it extension to make it 
compatible w ith  the International Classification of Health 
Problems in Primary Care (ICHPPC-2).1ii The GPs also 
register causes of death, inc lud ing those o f patients dying 
in hospital.
The four practices have a practice population of 
approximately 12 000. This number has remained stable 
over the years w ith a turnover o f less than 5 % per year. 
For each patient the fo llow ing  data are available: sex, 
date of birth, date of entry or departure in the Continuous
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Morbidity Registration, family composition, ancf social values could be traced in their records (diagnosis and 
class. Social class is defined according to profession as follow-up had only been based on urine glucose values).
well as education. A validated Dutch list of 11 categories 
is usually reduced to 3 as is the case here.
Selection o f Patients and Controls
All newly diagnosed Type 2 diabetic patients between 
1967 and 1989 (n =  265), including those who were 
under specialist medical care/ were included in the study 
cohort if the diagnostic evidence was in agreement with 
the W HO criteria.16 The diagnosis of all cases was 
reviewed using all available data from the patients'' files. 
Patients treated with insulin w ith in 1 year of diagnosis 
and who remained on it were regarded as Type 1 
(insulin-dependent) diabetes mellitus. All other patients 
with diabetes mellitus were considered Type 2, Irrespec­
tive of  their current  treatment.
For each patient a control was selected, matched for 
practice, sex, age (±3  months), and social class. Controls 
were selected from all patients on the practice lists at 
the time of diagnosis of the patients with Type 2 diabetes, 
with the exception of patients w ith known diabetes 
mellitus. There were no further exclusion criteria for 
controls. Patients and controls were followed up for 
mortality, cardiovascular morbidity, as well as cardio­
vascular risk factors from the time of diagnosis o f the 
Type 2 diabetic patient.
Cardiovascular morbidity included cerebrovascular 
accident, myocardial infarction, angina pectoris, heart 
failure,, and peripheral vascular disease. The follow ing 
risk factors were taken into account: hypertension, 
obesity, and hypercholesterolaemia. Mortality was speci­
fied according to the direct cause of death recorded.
A control patient developing clinical diabetes during 
follow-up was included in the study cohort. As a 
consequence two new controls were selected.
in 61 only normal blood glucose levels were found or 
only the criteria for impaired glucose tolerance were 
met and in 7 the medical records were incomplete.
The remaining 316 patients met the 1985 W H O - 
criteria for diabetes mellitus. Type 1 diabetes mellitus was 
diagnosed in 35 patients, in 9 it remained inconclusive 
whether they had Type 1 or 2 diabetes, and in 7 other 
patients a secondary cause of diabetes mellitus was 
present: pregnancy in 6 cases and pancreatectomy in 1.
Thus 265 Type 2 diabetic patients (112 men (40.3 %) 
and 153 women) were included in the study cohort. At 
diagnosis 60 % of these were aged 65 or under. The 
mean follow-up was 6.8 years (range from 0.8 to 22 
years). The matching succeeded completely for practice 
(100 %), sex (100 %), age (100 %, range 3 months), 
and social class (98 %).
Cardiovascular M orbidity
Prevalence at diagnosis and cumulative incidence rates 
after diagnosis of cardiovascular morbidity are presented 
in Table 1. The relative risk amounted to 1,76 (95 % Cl 
1.34-2.30) in Type 2 diabetic patients compared to 
controls. It was higher in men (1.94, 95 % Cl 1.28-2.93) 
than in women (1.63, 95 % Cl 1.15-2.32). Moreover,
5 years after diagnosis the cumulative incidence rates 
for cardiovascular diseases in this study cohort were 
already significantly higher (p <  0.05) in patients than in 
controls, except for myocardial infarction and peripheral 
vascular disease.
Data related to cardiovascular risk factors are presented 
in Table 2 . A higher prevalence of hypertension, obesity, 
and hypercholesterolaemia were present in patients 
compared to controls already at the time of diagnosis 
(p <  0.05).
Statistical Procedure
The cumulative incidence rates (first occurrence of the 
disease) of cardiovascular morbidity in the year of 
diagnosis and after 5, 10, and 15 years as well as 
mortality rates were calculated using the cohort life-table 
method.17 Statistical analysis was performed using the 
Mantel Haenszel procedure and the Cox Proportional 
Hazard regression model. Variables were entered into 
the multivariate regression model using the maximum 
partial likelihood ratio method. The data were analysed 
at the University of Nijmegen by means of the Statistical 
Analysis System (SAS 6 .06).18
* •»
Results
A total number of 427 patients were registered between 
1967 and 1989 as newly diagnosed diabetic patients by 
their GP. In 111 it was not possible to confirm the 
diagnosis for various reasons: in 43 no blood glucose
118
Mortality
Within the follow-up period 71 patients and 50 controls
died resulting in a relative risk of mortality in Type 2
diabetic patients of 1.54 (95 % Cl 1.07-2.23) compared
to controls. It was more predominant in women {1.(> 1,
95%  Cl 0.97-2.68) than in men (1.47 , 95 % Cl
0.86-2.50).
The 10-year mortality rates of the patients and controls 
were 20 % vs 36 % (p <  0.01), the median survival 
time 16 years vs 19 years (Figure 1). The cumulative 
survival rates of Type 2 diabetic patients turned out to 
be significantly different (p <  0 .01) from those of controls 
in the age group 65-74 (Figure 2).
The majority of deaths in the patient group were duo 
to cardiovascular disease, accounting for 46 of the 71 
deaths (64 %),  with coronary heart disease (32 %) as 
the most prominent cause of death (Table 3). The relative 
risk in Type 2 diabetic patients of death due to 
cardiovascular morbidity was 2.05 (95 % Cl 1.24-3.37)
W .I.C . D t  CiKAUW I I  AI .
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Table 1. Prevalence rates at diagnosis and cumulative incidence rates after diagnosis of cardiovascular morbidity in Type 2 dii 
patients (n = 265) compared to controls (n = 265), matched for practice, sex, age, and social class
nbetic
At diagnosis After 5 years After 10ï years After 15 years
End of study 
( 2 2  years)
Control Type 2 Control Type 2 Control Type 2 Control Type 2 Risk
ratio
95 % Cl
Cerebrovascular 1 2 3 7a 6 1 2 " 8 14* 1.34 0.84 2.14
accident (3) (6 ) (6 ) (17) (9) (2 2 ) (1 0 ) (23)
M y o ca rd i a 1 in fa rc t i o n 5 6 9 14 13 24b 2 0 32b 1.82 1,57-2.86
(13) (17) (2 2 ) (33) (25) (45) (29) (49)
Angina pectoris 6  13 13 19-’ 13 2 2 " 15 26a 1.78 1.14-2,77
(17) (34) (31) (50) (32) (52) (33) (54)
Heart failure 9 15 14 2 2 -' 24 3 0a 30 40* 1.52 1,04 2.21
(24) (40) (34) (55) (45) (65) (49) (70)
Peripheral vascular 3 5 8 1 2 1 0 23d 1 1 3 3 b 2 . 1 2 1.28-3.51
disease (8 ) (14) (2 0 ) (27) (2 2 ) (38) (23) (43)
Total cardiovascular Ï 9 24 30 461' 44 62b 56 7 4  b 1.76 1.34-2.30
morbidity1 (52) (63) (75) (115) (91) (138) (1 0 0 ) (148)
Results as percentage {the absolute number of c:ases are presented bet wee n parentheses).
Statistical differences wert' calculated using the log-rank test.
Cox proportional hazard regression was used to calculate risk ratio for Type 2 diabetic patients compared to controls.
*7? < O.o.1), l7> < 0.01.
‘ Total cardiovascular moirbidily represents all patients with at least one of the cardiovascular diagnoses.
Table 2. Prevalence r<.ites at diagnosis and cumulative incidence rates after diagnosis of cardiovascular risk factors; in Type 2
diabetic; patients (/? 2(>5) compared to controls (n — 265), matched for practice, sex, age, and social class
End of study
At diagnosis After 5 years After 10 years After 115 years ( 2 2  years)
Control Type 2! Control Type 2 Control ï '1Type 2 Control Type 2 Risk 85 % Cl
ratio
Hypertension 23 40" 27 4 7 b 32 5 3 h 32 45b 1.83 1.31-2,57
(0 1 ) (108) (69) (1 2 2 ) (75) (128) (75) (130)
Obesity 34 62b 41 6 8 11 48 70l> 50 72b 1.91 1.41-2,60
Body mass index ■?* 2i (91) (1C) 3) (108) ( I 79) (1 15) (182) (116) (183)
Hypercholesterolaemiaii} 3 K)a 6 1 5b 6 1 yh 8 2 0 b 2.70 1.12-6.56
(7) (26) (13) (37) (13) (39) (14) (40)
Results as percentage (tin* absolute number of rases are presented between parentheses).
Statistical differences were calculated using the log-rank test,
Cox proportional hazard regression was used to calculate risk ratio for Type 2 diabetes patients and controls 
•’/) < 0.1)5; ■»/> 0.01.
‘ Weight (kg)/height (nr).
dMean result of three measurements 7,0 mmol I 1,
compared to controls. There was only a slight difference 
between men (2.01, 95 % C! 0 .95-4 .27) and women 
(2.07, 95 % Cl 1.06-4.04).
Cox proportional hazard regression analysis of all 
patients and controls was used to determine the inde­
pendent factors significantly related with mortality. Dia­
betes itself (p = 0 .02) and pre-existing hypertension 
(p -  0 .02) turned out to be statistically sig 
factors related to mortality. Obesity (p =  0.55) and 
hypercholesterolaemia (p = 0.63) did not show statistical 
significance.
Discussion
This study clearly demonstrates that Type 2 diabetic 
patients in general practice are at higher risk of cardio­
vascular morbidity and m orta lity. The latter was more 
predominant in women than in men. In both sexes the 
excess mortality was com plete ly due to an excess in 
cardiovascular mortality. Population-based studies have 
reported an approximately two-fo ld  excess risk of all 
causes of death and a tw o- to four-fold excess risk from 
cardiovascular diseases among diabetic patients. 11 The
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Figure 1. Survival curves of Type 2 diabetic patients in general 
practice [+ ] (n = 265) and controls [■ ] (n = 265), matched 
for practice, sex, age, and social class in the period 1967-1989. 
Within the follow-up period 71 patients and 50 controls died 
resulting in a relative risk of mortality in Type 2 diabetic 
patients of 1.54 (95 % Cl 1.07-2.23) compared to controls. 
The 10-year mortality rates of the patients and controls were 
20 % vs 36 % (p <  0.01), the median survival time 16 years 
vs 19 years
Figure 2. Survival curves for three age categories of Type 2
diabetic patients [------ ) in general practice and controls [— |,
matched for practice, sex, age, and social class in the period 
1967-1989. The survival rates of Type 2 diabetic patients 
turned out to be significantly different (p <  0.01) from those 
of controls in the age group 65-74 |T |  (n =  77). In the age 
group 45-64 years [ + | (n =  114) statistical significance was 
not reached due to shortage of follow-up. In the age group 
over 75 years (■) {n =  52) it is age itself that has become the 
most powerful predictive factor
Table 3, Causes of death in Type 2 diabetic patients (n = 265) and controls (n = 265), 
matched for practice, sex, age, and social class in the period 1967-1989
Men Women
Control Type 2 Control Type 2
(n -  112) (n = 112) (n = 153) (n = 153)
Myocardial infarction 7 12 3 11*
Cerebrovascular accident 1 0 3 10a
Heart failure 2 5 5 3
Peripheral vascular disease 1 2 2 3
Total cardiovascular deaths 11 19 13 27 'a
Renal failure 1 0 1 0
Neoplasm 11 7 5 4
Others 2 6 6 8
Total number o f deaths 25 32 25 39
Results as absolute numbers. 
np <  0 .0 1 .
majority of these studies gave excess mortality rates that 
were higher in women than in men.19-23. Other studies 
showed a higher excess mortality in Type 2 diabetic 
men compared to wom en .24“26 However, there were no 
such data available from general practice. Moreover, the 
different methodological approaches in the design of 
these studies lead particularly to selection bias.11'12 At 
least this problem was avoided in this study, which was 
based on all cases of diabetes mellitus diagnosed in 
routine general practice care over a period of 22 years. 
Patients who had moved to another area or died since 
the first diagnosis were included. Patients referred for 
hospital-based care were included as well, thus avoiding
referral bias. 12 Although the diagnostic criteria for 
diabetes mellitus have changed considerably during the 
observation period, all cases included in this study had 
diabetes mellitus according to the currently applied 
criteria.16 The definition of type of diabetes (1 or 2) was 
applied consistently throughout this study group. All 
morbidity data have been collected prospectively with 
scrupulous care for quality and consistency of regis­
tration .13
Type 2 diabetic patients in this study were also 
characterized by the well-known risk factors such as 
hypertension, obesity, and lipid abnormalities, associated 
with insulin resistance, known by Reaven's syndrome
120 W.J.C. DE GRAUW ET AL
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X.27 The high prevalence of hypertension at the time 
of diagnosis possibly reflects the increased risk of 
hypertension and hypertension treatment for the develop­
ment of diabetes.2a'2t) In the years fo llow ing the diagnosis, 
hypertension was diagnosed in a steadily increasing 
number of Type 2 diabetic patients, possibly reflecting 
the cardiovascular consequence of having diabetes 
mellitus.
Some limitations of this study should be taken into 
consideration as well. Firstly, it has been demonstrated 
that probably 50 % of all Type 2 diabetic patients are 
not known to their GP.30 It is unlikely that this might 
be the case in this study w ith its special attention for 
cardiovascular morbidity and risk factors, including 
diabetes mellitus itself.31'32 Secondly, statistical signifi­
cance was not reached for the differences in mortality, 
if distinguished for men and women separately, which 
was probably due to small absolute numbers. In the 
specific age group 45-64  years statistical significance 
was not reached due to shortage of follow-up. In the 
age group over 75 years it is age itself that has become 
the most powerful predictive factor. Thirdly, in theory 
bias might have been introduced by the exclusion of the 
43 newly diagnosed Type 2 diabetic patients with no 
blood glucose values on their records. The diagnostic 
criteria and the definition of the different types of diabetes 
in these patients could not be verified. Uncertainty in 
these respects would have damaged the study more than 
the exclusion of 14 % of the potential diabetic patients. 
Moreover, it seems unlikely that this exclusion w ill have 
influenced the results essentially because this selection 
was based on diagnostic criteria and not on the course, 
severity or outcome of the disease.
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